中风醒脑方联合西药治疗急性脑出血临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R743.34

基金项目:


Clinical Study of Zhongfeng Xingnao Prescription Combined with Western Medicine for Acute Cerebral Hemorrhage
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察中风醒脑方联合西药治疗急性脑出血的临床疗效。方法:按照随机对照原则将120例急性脑出血患者分为对照组和治疗组各60例,对照组在采用常规西药治疗基础上予依达拉奉静脉滴注,治疗组在对照组的治疗基础上加用中风醒脑方内服,2组均治疗14天。分别于治疗前和治疗后对2组进行神经功能缺损评分、中医症状评分,观察2组脑出血的吸收情况,比较2组临床疗效。结果:治疗后,2组神经功能缺损评分及中医症状评分均较治疗前下降(P<0.01),治疗组的神经功能缺损评分及中医症状评分均比对照组下降更明显(P<0.01)。治疗后,2组脑出血量均较治疗前减少(P<0.01);治疗组的脑出血量少于对照组 (P<0.01)。治疗组总有效率95.00%,对照组总有效率81.67%,2组比较,差异有统计学意义(P<0.05)。结论:中风醒脑方联合西药治疗急性脑出血,可有效改善患者的中医症状及神经功能损伤程度,促进脑出血吸收。

    Abstract:

    Objective:To observe the clinical effect of Zhongfeng Xingnao prescription combined with western medicine for acute cerebral hemorrhage.Methods:According to the principle of randomized control,divided 120 cases of patients with acute cerebral hemorrhage into the control group and the treatment group,60 cases in each group.The control group was given intravenous infusion of edaravone based on routine western medicine,while the treatment group was additionally given Zhongfeng Xingnao prescription for oral administration based on the treatment of the control group.Both groups were treated for 14 days.Respectively evaluated neurological deficit score and Chinese medicine clinical symptom score of the two groups before and after treatment.Observed the absorption of cerebral hemorrhage and compared the clinical effect in both groups.Results:After treatment,both neurological deficit scores and Chinese medicine symptom scores were decreased in both groups when compared with those before treatment(P<0.01).Neurological deficit scores and Chinese medicine symptom scores were declined more significantly in the treatment group than those in the control group(P< 0.01).After treatment,the amount of cerebral hemorrhage in both groups was lower than that before treatment(P< 0.01),and the amount of cerebral hemorrhage in the treatment group was less than that in the control group(P<0.01).The total effective rate was 95.00%in the treatment group and was 81.67%in the control group,the difference being significant(P<0.05).Conclusion:The therapy of Zhongfeng Xingnao prescription combined with western medicine edaravone for acute cerebral hemorrhage can effectively improve Chinese medicine symptoms and neurological impairment of patients,and can promote cerebral hemorrhagic absorption.

    参考文献
    相似文献
    引证文献
引用本文

钟文亮.中风醒脑方联合西药治疗急性脑出血临床研究[J].新中医,2018,50(1):19-22

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2018-01-05
  • 出版日期: